Clinical Trial Update: AUGMENTIN 1gm In Skin And Soft Tissue Infection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update showing completion of a study evaluating Augmentin 1 g for skin and soft tissue infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin and Soft Tissue Infections

Drugs mentioned

• Augmentin (amoxicillin/clavulanate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Skin Diseases, Infectious, Infection, Soft Tissue | Phase 4 | Status: COMPLETED